Resume-aware faculty matching

Find professors who actually fit you

Review faculty evidence in public, then use the workspace to turn your background into a shortlist, outreach, and meeting prep.

Profile-awarePaper evidenceSix agents
Lisa M. Abegglen

Lisa M. Abegglen

· Research Associate Professor

University of Utah · Pediatrics

Active 2013–2026

h-index18
Citations2.7k
Papers11475 last 5y
Funding

Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.

See your match with Lisa M. Abegglen — sign in to PhdFit.Sign in

About

Dr. Lisa M. Abegglen is a Research Associate Professor at the University of Utah and an investigator at Huntsman Cancer Institute. Her work focuses on understanding how animals naturally resist cancer and other diseases, and how these insights can be used to improve human health and wildlife conservation. She co-discovered that elephants have extra copies of the tumor suppressor gene TP53, which contributes to their enhanced cancer suppression and provides a model for developing new therapies. Dr. Abegglen also leads a cross-species biobanks, with samples from a large number of diverse species. Using these resources, her research explores the genetic and cellular mechanisms that influence cancer risk and immune defense, with an emphasis on translating evolutionary discoveries into novel strategies for cancer prevention and treatment. In addition, she studies elephant endotheliotropic herpesvirus-hemorrhagic disease (EEHV-HD), focusing on how harmful innate immune responses drive severity and how they might be targeted to improve survival and support conservation.

Research topics

  • Biology
  • Ecology
  • Genetics
  • Internal medicine
  • Medicine
  • Evolutionary biology
  • Pathology
  • Computational biology
  • Zoology
  • Anesthesia

Selected publications

  • Lifetime cancer prevalence and life history traits in mammals

    Evolution Medicine and Public Health · 2020 · 94 citations

    BACKGROUND: Cancer is a common diagnosis in many mammalian species, yet they vary in their vulnerability to cancer. The factors driving this variation are unknown, but life history theory offers potential explanations to why cancer defense mechanisms are not equal across species. METHODOLOGY: Here we report the prevalence of neoplasia and malignancy in 37 mammalian species, representing 11 mammalian orders, using 42 years of well curated necropsy data from the San Diego Zoo and San Diego Zoo Saf…

  • Elephant Genomes Reveal Accelerated Evolution in Mechanisms Underlying Disease Defenses

    Molecular Biology and Evolution · 2021 · 67 citations

    Senior authorCorresponding

    Disease susceptibility and resistance are important factors for the conservation of endangered species, including elephants. We analyzed pathology data from 26 zoos and report that Asian elephants have increased neoplasia and malignancy prevalence compared with African bush elephants. This is consistent with observed higher susceptibility to tuberculosis and elephant endotheliotropic herpesvirus (EEHV) in Asian elephants. To investigate genetic mechanisms underlying disease resistance, including…

  • Cancer Prevalence across Vertebrates

    Cancer Discovery · 2024-10-24 · 57 citations

    articleOpen access

    Cancer is pervasive across multicellular species, but what explains the differences in cancer prevalence across species? Using 16,049 necropsy records for 292 species spanning three clades of tetrapods (amphibians, sauropsids, and mammals), we found that neoplasia and malignancy prevalence increases with adult mass (contrary to Peto's paradox) and somatic mutation rate but decreases with gestation time. The relationship between adult mass and malignancy prevalence was only apparent when we contr…

  • Comparative Oncology: New Insights into an Ancient Disease

    iScience · 2020 · 35 citations

    Senior authorCorresponding

    Cancer has deep evolutionary roots and is an important source of selective pressure in organismal evolution. Yet, we find a great deal of variation in cancer vulnerabilities across the tree of life. Comparative oncology offers insights into why some species vary in their susceptibility to cancer and the mechanisms responsible for the diversity of cancer defenses. Here we provide an overview for why cancer persists across the tree of life. We then summarize current data on cancer in mammals, rept…

  • Evidence for improved DNA repair in the long-lived bowhead whale

    Nature · 2025-10-29 · 26 citations

    articleOpen access

Frequent coauthors

  • Daniel T. Chang

    400 shared
  • Robert H. Bell

    Durham University

    300 shared
  • J. Costello

    Centre National de la Recherche Scientifique

    300 shared
  • Lih‐Shen Chin

    Shanghai University of Traditional Chinese Medicine

    300 shared
  • Gary K. Steinberg

    Stanford Medicine

    300 shared
  • Erik P. Sulman

    New York University

    300 shared
  • Sylvia K. Plevritis

    300 shared
  • N. Saito

    300 shared

Education

  • PhD, Immunology and Molecular Pathogenesis

    Emory University

    2005
  • BS, Genetics

    University of Georgia

    1997

Similar researchers at University of Utah

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Lisa M. Abegglen

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup